GlassScriptPhysician profile
Brett M Bennett
NPI 1861868853
$6,019.85
in general payments reported to CMS, 2019-2025
20 companies · $1,577 in 2025
The $1,577 reported for 2025 was more than what 95% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $98.10 · 2021: $731 · 2022: $1,109 · 2023: $1,084 · 2024: $1,295 · 2025: $1,577.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,666 · Entertainment: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,666.09 |
| Entertainment | $289.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $637.12 | 2019-2025 | Hydrus Microstent, Clareon Panoptix Pro, Total30 |
| Abbvie INC. | $593.65 | 2022-2025 | Lumigan |
| Johnson & Johnson Surgical Vision, INC. | $446.81 | 2021-2024 | Tecnis Iol, Catalys System |
| Mallinckrodt Hospital Products INC. | $400.89 | 2022-2025 | Acthar |
| Optos, INC. | $387.62 | 2020-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Dompe US, INC. | $375.71 | 2023-2025 | Oxervate |
| Sight Sciences, INC. | $367.61 | 2022-2025 | Tearcare System, Omni Surgical System |
| Glaukos Corporation | $343.92 | 2021-2025 | Idose, Idosetr |
| Tarsus Pharmaceuticals, INC. | $306.11 | 2024-2025 | Xdemvy |
| Coopervision INC. | $282.12 | 2022-2024 | Clariti Contact Lens, Biofinity Contact Lens |
| Carl Zeiss Meditec USA, INC. | $279.40 | 2023 | Cirrus Hd-Oct, Clarus |
| Biotissue Holdings INC. | $246.75 | 2025 | |
| Aerie Pharmaceuticals, INC. | $235.58 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $223.34 | 2023-2025 | Cequa |
| Allergan, INC. | $205.88 | 2021-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $203.12 | 2022-2024 | Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Ivantis, INC | $175.10 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $150.00 | 2022 | |
| Ocular Therapeutix, INC. | $93.35 | 2023-2024 | Dextenza |
| Harrow Eye, LLC | $65.77 | 2024-2025 | Tobradex St, Natacyn, Verkazia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.